RE:RE:When you calculate revenue & profit .40 is nothing QuestCap and Sona are two different companies with different business models. SONA developed Antigen testing kits and ran to $16, investors thinking "Sona" to get approval by Health Canada and EUA. That never happened, and it came crashing back to a Dollar. Now up again to $4 on CE in Europe approval. SONA share price goes up or down, based on speculation, not based on earned revenue.
QuestCap is becoming Medical services company with Covid-19 testing centres. Once Covid-19 testing demand slows down, they can easily change these testing centres to offer drug tests, flu shots, Vaccination centres or all kinds of In-Vetro testing services.
QuestCap share price does not go up or down based on speculation. Medivolve does generate revenue and a lot more than anyone small-cap testing kits manufacturer. Also, this is reassuring revenue directly from consumers in need of testing. Selling testing kits, you see a lot of competition, and as per testing centres performing covid-19 testing, not much.
Medivolve probably won't run like SONA, on speculation. It will run-up slowly but surely based on revenue and EBTIDA. Medivolve is becoming a real company generating revenue and should be able to attract big-league investors. If Medivolve keeps up the progress, as they say, Medivolve can be trading above $15-$20 by the end of April.
Compare SONA and Medivolve side by side.
- At this point, SONA generates no revenue.
- Medivolve is generating revenue in millions and with a projected EBTIDA of 55%.
SONA Model: You can sell testing to a distributor or testing centres and, the option is limited. You sell a million testing kits, then nothing for the next 3 to 6 months. This model needs to look for a new distributor or testing centres every day or month, and this market is very competitive.
Medivolve Model: Collection sites sell these covid-19 tests to the public and generate recurring revenue. These collection sites can be moved from one place to another busy location. Once testing demand slows down, they can offer drug tests, flu shots, Vaccination centres or all kinds of In-Vetro testing services.
maidenmist wrote: Sarb: We all know that people sign off with M.P.O. Indeed that is the case. SO, what I'm asking is, based on the numbers you have thrown around, in your conservative opinion, what should the stock price be? Can you see a SONA in the works where she runs to 16 in 7 months? Love to hear your take on it. You seem quite knowledgable in your assesment, hence me reaching out to you. Thanks in advance